In addition, genetic inhibition of CBP promoted cell differentiation and p53-dependent cell senescence in chronic myeloid leukemia independent of BCR-ABL status [44]. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.